Rozen F - Search Results

1

Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators.

Deal C, Ma J, Wilkin F, Paquette J, Rozen F, Ge B, Hudson T, Stampfer M, Pollak M. Deal C, et al. Among authors: rozen f. J Clin Endocrinol Metab. 2001 Mar;86(3):1274-80. doi: 10.1210/jcem.86.3.7280. J Clin Endocrinol Metab. 2001. PMID: 11238520

2

Antiproliferative action of vitamin D-related compounds and insulin-like growth factor-binding protein 5 accumulation.

Rozen F, Yang XF, Huynh H, Pollak M. Rozen F, et al. J Natl Cancer Inst. 1997 May 7;89(9):652-6. doi: 10.1093/jnci/89.9.652. J Natl Cancer Inst. 1997. PMID: 9150190

3

Antiproliferative action of tumor necrosis factor-alpha on MCF-7 breastcancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation.

Rozen F, Zhang J, Pollak M. Rozen F, et al. Int J Oncol. 1998 Oct;13(4):865-9. doi: 10.3892/ijo.13.4.865. Int J Oncol. 1998. PMID: 9735418

4

Inhibition of insulin-like growth factor I receptor signaling by the vitamin D analogue EB1089 in MCF-7 breast cancer cells: A role for insulin-like growth factor binding proteins.

Rozen F, Pollak M. Rozen F, et al. Int J Oncol. 1999 Sep;15(3):589-94. doi: 10.3892/ijo.15.3.589. Int J Oncol. 1999. PMID: 10427145

5

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN. Foulkes WD, et al. Among authors: rozen f. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2465-9. Clin Cancer Res. 1997. PMID: 9815648

6

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR. Foulkes WD, et al. Among authors: rozen f. Ann Oncol. 2000 Mar;11(3):307-13. doi: 10.1023/a:1008340723974. Ann Oncol. 2000. PMID: 10811497 Free article.

7

Oxytocin receptor gene expression in the rat uterus during pregnancy and the estrous cycle and in response to gonadal steroid treatment.

Larcher A, Neculcea J, Breton C, Arslan A, Rozen F, Russo C, Zingg HH. Larcher A, et al. Among authors: rozen f. Endocrinology. 1995 Dec;136(12):5350-6. doi: 10.1210/endo.136.12.7588281. Endocrinology. 1995. PMID: 7588281

8

Survival of patients with breast cancer and BRCA1 mutations.

Foulkes WD, Wong N, Rozen F, Brunet JS, Narod SA. Foulkes WD, et al. Among authors: rozen f. Lancet. 1998 May 2;351(9112):1359-60. doi: 10.1016/S0140-6736(05)79091-7. Lancet. 1998. PMID: 9643825 No abstract available.

9

Oxytocin and oxytocin receptor gene expression in the uterus.

Zingg HH, Rozen F, Chu K, Larcher A, Arslan A, Richard S, Lefèbvre D. Zingg HH, et al. Among authors: rozen f. Recent Prog Horm Res. 1995;50:255-73. doi: 10.1016/b978-0-12-571150-0.50015-9. Recent Prog Horm Res. 1995. PMID: 7740160 Review. No abstract available.

10

Structure, characterization, and expression of the rat oxytocin receptor gene.

Rozen F, Russo C, Banville D, Zingg HH. Rozen F, et al. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):200-4. doi: 10.1073/pnas.92.1.200. Proc Natl Acad Sci U S A. 1995. PMID: 7816817 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page